Treatment modalities
Tools selected with purpose. Not with a menu.
The treatments available at this clinic are not offered as standalone services. They are tools — selected after assessment, integrated into a plan, and used because the clinical evidence supports their use for your specific concern.
This is not a spa. It's a medical clinic. The difference matters.
This clinic uses medical-grade energy-based technologies including the Etherea platform — a versatile system that allows multiple treatment modalities within a single device. These are used to address pigmentation, vascular concerns, skin texture, and overall skin quality. Treatment parameters are set individually based on your skin type, concern, and assessment findings — not on a standard protocol.
Microneedling and mesotherapy-based approaches that work by stimulating the skin's own repair response. Used to improve skin structure, texture, and quality over time. These are often used as part of a broader plan rather than as standalone treatments.
Including PRP, PRF+, BioFiller, and biostimulatory approaches that support tissue repair and skin function from within. Regenerative treatments work with your skin's own biology — they are not a shortcut. They are a considered addition to a plan where the evidence supports their use.
Prescription Treatments
Where clinically appropriate, prescription-only cosmetic injectable treatments may be part of your management plan. These are discussed during consultation only, in accordance with TGA and AHPRA guidelines.
Medical-grade skincare is not an add-on. For many patients it is the foundation — the thing that maintains what treatments achieve and addresses what procedures alone cannot. Skincare recommendations are personalised after assessment and form part of your treatment plan.
A note on how treatments are selected
No treatment is recommended at this clinic because it's trending, because it's profitable, or because it's what the patient came in asking for. Treatment is recommended when the clinical assessment supports it, when the evidence backs it, and when the risk-benefit conversation has happened properly.